Stay updated on AK104+Lenvatinib in Advanced Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the AK104+Lenvatinib in Advanced Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AK104+Lenvatinib in Advanced Hepatocellular Carcinoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page now presents details for a completed Phase 2 study of combination therapy for untreated metastatic pancreatic cancer, including its interventions, participant criteria, measured outcomes, and study documents.
    Difference
    51%
    Check dated 2026-11-10T14:34:29.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The site revision label in the footer changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T15:46:43.000Z thumbnail image
  3. Check
    23 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces updates to terminology, including using “Super Intelligence” in place of “Artificial Intelligence.” The site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T14:49:26.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision identifier was updated from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-13T14:48:57.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Removed the 403 Forbidden error page HTML and the Home link from the page. This indicates the previously blocked page content has been removed, potentially restoring access to the study details.
    Difference
    0.5%
    Check dated 2026-09-29T16:38:39.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error instead of the expected study content. This prevents viewing the study details and related materials on that page.
    Difference
    19%
    Check dated 2026-09-22T22:03:17.000Z thumbnail image

Stay in the know with updates to AK104+Lenvatinib in Advanced Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AK104+Lenvatinib in Advanced Hepatocellular Carcinoma Clinical Trial page.